SCHEMBL23958817

SCHEMBL23958817

Cc1c(C(C)(C)O)cc(Cl)nc1-c1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.42
ADORA1 P30542 3/20 0.42
ADORA2B P29275 3/20 0.42
ADORA3 P0DMS8 1/20 0.42
DHODH Q02127 5/20 0.39
MAPK14 Q16539 1/20 0.37
SLC34A1 Q06495 3/20 0.36
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
CFTR P13569 2/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930265 0.87 ADORA2A (0.40) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL23930153 0.87 ADORA2A (0.40) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL30007319 0.87 ADORA2A (0.40) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL23958683 0.78 ADORA2A (0.39) ADORA2AADORA1ADORA2BADORA3DHODH
SCHEMBL31309443 0.75 ADORA2A (0.43) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL26728890 0.73 ADORA2A (0.40) ADORA2AADORA1ADORA2BADORA3CFTR
SCHEMBL24363599 0.72 ALOX5 (0.46) ADORA2AADORA1ADORA2BADORA3DHODH
SCHEMBL26728887 0.71 ADORA1 (0.38) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL30007134 0.71 SLC34A1 (0.36) ADORA2AADORA1ADORA2BADORA3DHODH
SCHEMBL25686851 0.71 SLC34A1 (0.36) ADORA2AADORA1ADORA2BADORA3DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed